Preface content

  • Pirbright collaboration uncovers licensed drugs as potential treatments

    for poxvirus infections, including mpox and smallpox

  • Meet Pirbright's new Fellows

  • Pirbright secures significant BBSRC investment to advance world-class research

  • Professor Bryan Charleston elected as Fellow of the Royal Society

  • Take a look at our training courses

  • Current vacancies at Pirbright

  • Director's vision

Innovation and collaboration

Trim content

® The Pirbright Institute 2023 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.